Regulatory Q&A Forum

Ask questions, share knowledge, and get help from the regulatory community

When medical device manufacturers budget for EU MDR compliance, how can they accurately estimate the annual cost of contracting a "Person Responsible for Regulatory Compliance (PRRC) as a Service," co...

💬 1 👁️ 34 👍 1
Asked: 2 months ago
Asked by Lo H. Khamis

For non-EU manufacturers preparing for the comprehensive REACH restrictions on Per- and Polyfluoroalkyl Substances (PFAS), what is a robust framework for selecting a qualified Only Representative (OR)...

💬 1 👁️ 18 👍 1
Asked: 2 months ago
Asked by Lo H. Khamis

Given the increasing regulatory pressure on per- and polyfluoroalkyl substances (PFAS) under the EU REACH regulation, particularly with the European Chemicals Agency (ECHA) advancing its universal res...

💬 1 👁️ 19 👍 1
Asked: 2 months ago
Asked by Lo H. Khamis

For non-EU companies, including medical device manufacturers, placing products on the European market often requires compliance with the REACH (Registration, Evaluation, Authorisation and Restriction ...

💬 1 👁️ 32 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

When developing a premarket submission for a Class II software-enabled device, such as a wearable cardiac monitor, sponsors must navigate a complex set of regulatory expectations. Beyond demonstrating...

💬 1 👁️ 20 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

For a sponsor developing a novel Class II in vitro diagnostic (IVD) device, what is the most effective way to integrate FDA's Special Controls into the product development lifecycle and 510(k) submiss...

💬 1 👁️ 16 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

How should sponsors of connected medical devices effectively integrate cybersecurity management into their existing Quality Management System (QMS) to align with FDA's expectations for total product l...

💬 1 👁️ 25 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

With the Modernization of Cosmetics Regulation Act (MoCRA) mandating that foreign cosmetic facilities designate a U.S. Agent, many companies are evaluating the associated costs. However, focusing sole...

💬 1 👁️ 7 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

Given the requirement under the Modernization of Cosmetics Regulation Act (MoCRA) for foreign cosmetic facilities to designate a U.S. Agent, what key criteria should be used to evaluate and select the...

💬 1 👁️ 36 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

When medical device manufacturers, particularly small and medium-sized enterprises, plan their budgets for 2025, a key consideration is the cost of engaging a "Person Responsible for Regulatory Compli...

💬 1 👁️ 20 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

Under the EU Medical Device Regulation (MDR), manufacturers must appoint a Person Responsible for Regulatory Compliance (PRRC). For many small and medium-sized enterprises (SMEs), outsourcing this fun...

💬 1 👁️ 38 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

With ECHA's 2026 enforcement project (REF-14) and its associated pilot project specifically targeting Only Representatives (ORs), how should non-EU manufacturers critically evaluate and select a REACH...

💬 1 👁️ 23 👍 1
Asked: 2 months ago
Asked by Lo H. Khamis

When developing a Class II in vitro diagnostic (IVD) device, how do FDA's regulations in 21 CFR and associated Class II Special Controls Guidance Documents work together to establish the specific requ...

💬 1 👁️ 25 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

When preparing a premarket submission for a connected medical device, such as a Class II Software as a Medical Device (SaMD) or a network-enabled diagnostic instrument, how should sponsors effectively...

💬 1 👁️ 27 👍 1
Asked: 2 months ago
Asked by Lo H. Khamis

With upcoming WEEE and EPR compliance deadlines, particularly new requirements taking effect by 2026, medical device manufacturers face a critical strategic decision: how to select a compliance partne...

💬 1 👁️ 33 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

With significant environmental compliance deadlines approaching in 2026, manufacturers of medical devices, particularly those incorporating electronics, face increasing pressure to comply with Waste E...

💬 1 👁️ 63 👍 1
Asked: 2 months ago
Asked by Lo H. Khamis

When budgeting for EU MDR compliance, particularly for 2026 and beyond, many medical device manufacturers consider outsourcing the Person Responsible for Regulatory Compliance (PRRC) role. While speci...

💬 1 👁️ 31 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

As medical device manufacturers plan their compliance strategies for 2026 and beyond under the EU MDR, how should they strategically evaluate and select a 'PRRC as a Service' provider to ensure both r...

💬 1 ✓ 👁️ 15 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

When a non-EU manufacturer of a medical device, such as a Class II IVD like an acute kidney injury test system (governed by regulations like 21 CFR 862.1220), needs to comply with broad European chemi...

💬 1 👁️ 36 👍 1
Asked: 2 months ago
Asked by Lo H. Khamis
Showing page 23 of 54 (1079 total questions)